Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells

Journal of Neuro-Oncology

Volumn 112, Issue 1, 2013, Pages 73-82

  Wang, Qi ^a   Qian, Jun ^a   Wang, Junyu ^a   Luo, Chun ^a   Chen, Juxiang ^a   Hu, Guohan ^a   Lu, Yicheng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chemoresistance; Glioblastoma; Invasion; RLIP76; TMZ

Indexed keywords

CYCLIN D1; GELATINASE A; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; LENTIVIRUS VECTOR; PROTEIN RLIP76; SHORT HAIRPIN RNA; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; ENZYME INHIBITION; GLIOMA CELL; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; ZYMOGRAPHY;

ANTINEOPLASTIC AGENTS, ALKYLATING; ATP-BINDING CASSETTE TRANSPORTERS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CYCLIN D1; DACARBAZINE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; GREEN FLUORESCENT PROTEINS; GTPASE-ACTIVATING PROTEINS; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM INVASIVENESS; P-GLYCOPROTEIN; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION;

EID: 84874667032     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1045-2     Document Type: Article

References (35)

1. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492-507
2. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60:166-193
3. Singhal SS, Singhal J, Nair MP, Lacko AG, Awasthi YC, Awasthi S (2007) Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer. Int J Oncol 30:717-725
4. Singhal SS, Sehrawat A, Sahu M, Singhal P, Vatsyayan R, Rao Lelsani PC, Yadav S, Awasthi S (2010) Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer. Int J Cancer 126:1327-1338
5. Singhal SS, Sehrawat A, Mehta A, Sahu M, Awasthi S (2009) Functional reconstitution of RLIP76 catalyzing ATP-dependent transport of glutathione-conjugates. Int J Oncol 34:191-199
6. Drake KJ, Singhal J, Yadav S, Nadkar A, Pungaliya C, Singhal SS, Awasthi S (2007) RALBP1/RLIP76 mediates multidrug resistance. Int J Oncol 30:139-144
7. Awasthi S, Singhal SS, Singhal J, Yang Y, Zimniak P, Awasthi YC (2003) Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity. Int J Oncol 22:721-732
8. Awasthi S, Singhal SS, Singhal J, Cheng J, Zimniak P, Awasthi YC (2003) Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76. Int J Oncol 22:713-720
9. Awasthi S, Hallene KL, Fazio V, Singhal SS, Cucullo L, Awasthi YC, Dini G, Janigro D (2005) RLIP76, a non-ABC transporter, and drug resistance in epilepsy. BMC Neurosci 6:61 (Pubitemid 41554978)
10. Awasthi S, Cheng J, Singhal SS, Saini MK, Pandya U, Pikula S, Bandorowicz-Pikula J, Singh SV, Zimniak P, Awasthi YC (2000) Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin. Biochemistry 39:9327-9334 (Pubitemid 30626323)
11. Stuckler D, Singhal J, Singhal SS, Yadav S, Awasthi YC, Awasthi S (2005) RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer. Cancer Res 65:991-998 (Pubitemid 40216461)
12. Awasthi S, Singhal SS, Srivastava SK, Zimniak P, Bajpai KK, Saxena M, Sharma R, Ziller SA III, Frenkel EP, Singh SV et al (1994) Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein. J Clin Invest 93:958-965
13. Awasthi S, Singhal SS, Pandya U, Gopal S, Zimniak P, Singh SV, Awasthi YC (1999) ATP-dependent colchicine transport by human erythrocyte glutathione conjugate transporter. Toxicol Appl Pharmacol 155:215-226 (Pubitemid 29153369)
14. Yadav S, Zajac E, Singhal SS, Singhal J, Drake K, Awasthi YC, Awasthi S (2005) POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis. Biochem Biophys Res Commun 328:1003-1009 (Pubitemid 40238735)
15. Singhal SS, Yadav S, Vatsyayan R, Chaudhary P, Borvak J, Singhal J, Awasthi S (2009) Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis. Cancer Lett 283:152-158
16. Hu Y, Mivechi NF (2003) HSF-1 interacts with Ral-binding protein 1 in a stress-responsive, multiprotein complex with HSP90 in vivo. J Biol Chem 278:17299-17306 (Pubitemid 36799613)
17. Vatsyayan R, Lelsani PC, Awasthi S, Singhal SS (2010) RLIP76: a versatile transporter and an emerging target for cancer therapy. Biochem Pharmacol 79:1699-1705
18. Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21:1624-1636 (Pubitemid 46594118)
19. Singhal SS, Singhal J, Yadav S, Sahu M, Awasthi YC, Awasthi S (2009) RLIP76: a target for kidney cancer therapy. Cancer Res 69:4244-4251
20. Singhal SS, Singhal J, Yadav S, Dwivedi S, Boor PJ, Awasthi YC, Awasthi S (2007) Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1). Cancer Res 67:4382-4389 (Pubitemid 46815087)
21. Singhal SS, Roth C, Leake K, Singhal J, Yadav S, Awasthi S (2009) Regression of prostate cancer xenografts by RLIP76 depletion. Biochem Pharmacol 77:1074-1083
22. Singhal SS, Awasthi YC, Awasthi S (2006) Regression of melanoma in a murine model by RLIP76 depletion. Cancer Res 66:2354-2360
23. Singhal J, Yadav S, Nagaprashantha LD, Vatsyayan R, Singhal SS, Awasthi S (2011) Targeting p53-null neuroblastomas through RLIP76. Cancer Prev Res (Phila) 4:879-889
24. Wang J, Wang Q, Cui Y, Liu ZY, Zhao W, Wang CL, Dong Y, Hou L, Hu G, Luo C, Chen J, Lu Y (2012) Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells. J Neurooncol 106:473-484
25. Singhal SS, Yadav S, Singhal J, Zajac E, Awasthi YC, Awasthi S (2005) Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin. Biochem Pharmacol 70:481-488 (Pubitemid 40905120)
26. Vatsyayan R, Chaudhary P, Lelsani PC, Singhal P, Awasthi YC, Awasthi S, Singhal SS (2009) Role of RLIP76 in doxorubicin resistance in lung cancer. Int J Oncol 34:1505-1511
27. Herlyn M, Malkowicz SB (1991) Regulatory pathways in tumor growth and invasion. Lab Invest 65:262-271
28. Bouterfa H, Darlapp AR, Klein E, Pietsch T, Roosen K, Tonn JC (1999) Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions. J Neurooncol 44:23-33 (Pubitemid 29515646)
29. Nakada M, Okada Y, Yamashita J (2003) The role of matrix metalloproteinases in glioma invasion. Front Biosci 8:e261-e269
30. Wang M, Wang T, Liu S, Yoshida D, Teramoto A (2003) The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathol 20:65-72 (Pubitemid 38146273)
31. Komatsu K, Nakanishi Y, Nemoto N, Hori T, Sawada T, Kobayashi M (2004) Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas. Brain Tumor Pathol 21:105-112 (Pubitemid 40187984)
32. Thorns V, Walter GF, Thorns C (2003) Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Anticancer Res 23:3937-3944 (Pubitemid 37474346)
33. Grana X, Reddy EP (1995) Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11:211-219
34. Mousseau M, Chauvin C, Nissou MF, Chaffanet M, Plantaz D, Pasquier B, Schaerer R, Benabid A (1993) A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumours. Eur J Cancer 29A:753-759 (Pubitemid 23077060)
35. Sugawara I, Yamada H, Nakamura H, Sumizawa T, Akiyama S, Masunaga A, Itoyama S (1995) Preferential expression of the multidrug-resistance-associated protein (MRP) in adenocarcinoma of the lung. Int J Cancer 64:322-325